173 related articles for article (PubMed ID: 17326668)
1. Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells.
Dornetshuber R; Heffeter P; Kamyar MR; Peterbauer T; Berger W; Lemmens-Gruber R
Chem Res Toxicol; 2007 Mar; 20(3):465-73. PubMed ID: 17326668
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
3. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
Chiu CC; Lin CH; Fang K
Apoptosis; 2005 May; 10(3):643-50. PubMed ID: 15909125
[TBL] [Abstract][Full Text] [Related]
4. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
Hattangadi DK; DeMasters GA; Walker TD; Jones KR; Di X; Newsham IF; Gewirtz DA
Biochem Pharmacol; 2004 Nov; 68(9):1699-708. PubMed ID: 15450935
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction of p53-independent apoptotic pathway induced by hexavalent chromium in U937 cells.
Hayashi Y; Kondo T; Zhao QL; Ogawa R; Cui ZG; Feril LB; Teranishi H; Kasuya M
Toxicol Appl Pharmacol; 2004 Jun; 197(2):96-106. PubMed ID: 15163545
[TBL] [Abstract][Full Text] [Related]
6. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
Wu GS; Ding Z
Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.
Galmarini CM; Falette N; Tabone E; Levrat C; Britten R; Voorzanger-Rousselot N; Roesch-Gateau O; Vanier-Viornery A; Puisieux A; Dumontet C
Br J Cancer; 2001 Sep; 85(6):902-8. PubMed ID: 11556844
[TBL] [Abstract][Full Text] [Related]
8. c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitor.
Russo P; Arzani D; Trombino S; Falugi C
J Pharmacol Exp Ther; 2003 Jan; 304(1):37-47. PubMed ID: 12490573
[TBL] [Abstract][Full Text] [Related]
9. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr.
Shostak LD; Ludlow J; Fisk J; Pursell S; Rimel BJ; Nguyen D; Rosenblatt JD; Planelles V
Exp Cell Res; 1999 Aug; 251(1):156-65. PubMed ID: 10438581
[TBL] [Abstract][Full Text] [Related]
10. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
Hemmati PG; Normand G; Verdoodt B; von Haefen C; Hasenjäger A; Güner D; Wendt J; Dörken B; Daniel PT
Oncogene; 2005 Jun; 24(25):4114-28. PubMed ID: 15750619
[TBL] [Abstract][Full Text] [Related]
11. BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells.
Tong QS; Zheng LD; Wang L; Liu J; Qian W
BMC Cancer; 2004 Jul; 4():33. PubMed ID: 15248898
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
Gatti L; Supino R; Perego P; Pavesi R; Caserini C; Carenini N; Righetti SC; Zuco V; Zunino F
Cell Death Differ; 2002 Dec; 9(12):1352-9. PubMed ID: 12478472
[TBL] [Abstract][Full Text] [Related]
13. Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis.
Cheng YL; Chang WL; Lee SC; Liu YG; Chen CJ; Lin SZ; Tsai NM; Yu DS; Yen CY; Harn HJ
Life Sci; 2004 Aug; 75(13):1579-94. PubMed ID: 15261763
[TBL] [Abstract][Full Text] [Related]
14. Isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis, induces cell cycle arrest and apoptosis in human colon cancer cells.
Frédérich M; Bentires-Alj M; Tits M; Angenot L; Greimers R; Gielen J; Bours V; Merville MP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1103-10. PubMed ID: 12604687
[TBL] [Abstract][Full Text] [Related]
15. [Molecular bases of the programmed cell death process: implications of tumor suppressor protein p53 and other proteins in the control of cell cycle. Mechanisms of apoptotic action. Review].
Merino JJ; Cordero-Campaña MI
Invest Clin; 1998 Dec; 39(4):323-58. PubMed ID: 9927805
[TBL] [Abstract][Full Text] [Related]
16. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells.
Corbiere C; Liagre B; Terro F; Beneytout JL
Cell Res; 2004 Jun; 14(3):188-96. PubMed ID: 15225412
[TBL] [Abstract][Full Text] [Related]
17. Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line.
Ookawa K; Tsuchida S; Adachi J; Yokota J
Oncogene; 1997 Mar; 14(12):1389-96. PubMed ID: 9136982
[TBL] [Abstract][Full Text] [Related]
18. Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells.
Pruschy M; Resch H; Shi YQ; Aalame N; Glanzmann C; Bodis S
Br J Cancer; 1999 May; 80(5-6):693-8. PubMed ID: 10360645
[TBL] [Abstract][Full Text] [Related]
19. Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog.
Mujoo K; Watanabe M; Khokhar AR; Siddik ZH
Prostate; 2005 Jan; 62(1):91-100. PubMed ID: 15389812
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and cell recovery in response to oxidative stress in p53-deficient prostate carcinoma cells.
Bataller M; Portugal J
Arch Biochem Biophys; 2005 May; 437(2):151-8. PubMed ID: 15850555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]